HGF activates HGF/c-Met, MAPK/ERK1/2, and PI3K/AKT pathways in tumour cells, further recruits M2 TAMs, and thus sustains hepatoma growth and metastasis in a feed-forward manner. Here, MET is linked to hepatocellular carcinoma.